No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
TAK Takeda Pharmaceutical
- 13.100
- +0.090+0.69%
Close Dec 20 16:00 ET
- 13.100
- 0.0000.00%
Post 20:01 ET
41.68BMarket Cap22.66P/E (TTM)
13.190High13.020Low1.85MVolume13.040Open13.010Pre Close24.28MTurnover0.06%Turnover Ratio45.17P/E (Static)3.18BShares14.74252wk High0.95P/B39.89BFloat Cap12.29352wk Low0.63Dividend TTM3.05BShs Float19.900Historical High4.82%Div YieldTTM1.31%Amplitude11.308Historical Low13.131Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating
Express News | Hikma - Acquires Rights to a Portfolio of Takeda Brands for the Mena Region
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Takeda Pharmaceutical: Revised Extraordinary Report
Express News | Takeda Pharmaceutical's CD38 monoclonal antibody has been approved for clinical use again in China.
Takeda Pharmaceutical (TAK.US) CD38 monoclonal antibody has been approved for clinical use again in China.
Takeda Pharmaceutical's CD38 monoclonal antibody has been approved for clinical use in China again.
Heat List
US
Overall
Symbol
Price
% Chg
No Data
